Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Change in Account Payables (2022 - 2023)

Bioadaptives' Change in Account Payables history spans 2 years, with the latest figure at -$470.0 for Q3 2023.

  • For Q3 2023, Change in Account Payables changed N/A year-over-year to -$470.0; the TTM value through Mar 2024 reached -$470.0, changed N/A, while the annual FY2023 figure was -$470.0, 126.07% down from the prior year.
  • Change in Account Payables for Q3 2023 was -$470.0 at Bioadaptives, down from $1803.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $1803.0 in Q1 2022 and bottomed at -$470.0 in Q3 2023.